LPL Financial
CODX

LPL Financial’s Co-Diagnostics CODX Stock Holding History

LPL Financial’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-468
Closed -$87K – 4441
2022
Q1 		$87K Sell
468
-100
-18% -$20.7K ﹤0.01% 3999
2021
Q4 		$152K Sell
568
-804
-59% -$211K ﹤0.01% 4053
2021
Q3 		$400K Sell
1,372
-200
-13% -$58.4K ﹤0.01% 3420
2021
Q2 		$389K Sell
1,572
-280
-15% -$72K ﹤0.01% 3373
2021
Q1 		$530K Buy
1,852
+98
+6% +$39.1K ﹤0.01% 2965
2020
Q4 		$489K Buy
1,754
+193
+12% +$71.5K ﹤0.01% 2781
2020
Q3 		$637K Buy
1,561
+568
+57% +$292K ﹤0.01% 2280
2020
Q2 		$576K Buy
+993
New +$453K ﹤0.01% 2269

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial's CODX Position: Q2 2022 in Review

LPL Financial sold out of Co-Diagnostics (CODX) in Q2 2022, closing a stake of 468 shares — an estimated $87K sold.

LPL Financial first reported a position in CODX in Q2 2020 and held it in 8 quarters. The position peaked at $637K in Q3 2020. 69 funds tracked by Wall St. Rank hold CODX as of Q2 2022.

  • LPL Financial reported no remaining Co-Diagnostics position as of Q2 2022 after selling out during the quarter.
  • LPL Financial sold 468 Co-Diagnostics shares in Q2 2022, an estimated $87K.
  • LPL Financial first reported a position in Co-Diagnostics in Q2 2020 and held it in 8 quarters.
  • LPL Financial's Co-Diagnostics position peaked at $637K in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2022.

Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.